Search Results 621-630 of 38925 for Two-phase

1. Breast-Conserving Surgery and Radiation Therapy in Patients with Multiple Ipsilateral Breast Cancer - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

2. Microbiota Restoration Therapy For Recurrent Clostridium Difficile Infection - Mayo Clinic

   Study phase. 0. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

3. Clinical trials - Oncology (Medical)

   ... phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti ... The study will be performed in two phases: Phase I will be performed for ...

4. Oncology (Medical) - Clinical trials

   The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II ...

5. A Phase 1b/2 Study Of CAR T Cell Therapy Targeting CD19 And BCMA In Participants With Relapsed Or Refractory AL Amyloidosis. - Mayo Clinic

   A Phase 1b/2 Study Of CAR T Cell Therapy Targeting CD19 And BCMA In Participants With Relapsed Or Refractory AL Amyloidosis.

6. PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer - Mayo Clinic

   A Phase II study to investigate the potential utility of PD 0332991 in the treatment of early stage ER+ Human epidermal growth factor receptor 2 (HER2)- breast ...

7. A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

8. A 52-week Study Of Rilzabrutinib Efficacy And Safety Compared To Placebo In Adults Diagnosed With IgG4-related Disease - Mayo Clinic

   This is a Phase 3, parallel group, 2-arm, randomized, double blind, placebo-controlled, 52-week treatment study to assess the efficacy and safety of ...

9. A Phase 1/2 Study to Evaluate MEDI4736 - Clinical Trials

   This is a multicenter, open-label, first-time-in-human study with a standard 3+3 dose-escalation phase in subjects with advanced solid tumors followed by an ...

10. Parkinson's test (a-Synuclein seed amplification assay) - Mayo Clinic

    Overview. A new Parkinson's test can identify people with Parkinson's disease during the early stages or even before symptoms begin. The test is called an alpha ...